Published by Josh White on 16th November 2022
(Sharecast News) - Clinical-stage drug developer Evgen Pharma has dosed the first group of healthy volunteers in its placebo-controlled, dose-escalating, randomised phase 1 and 1b clinical trial, it announced on Wednesday.
URL: http://www.digitallook.com/dl/news/story/33114180/...